The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 10,019 | 19,165 |
| Provision for credit losses | 3,876 | 2,315 |
| Depreciation | 376 | 787 |
| Accretion on loans | 557 | 1,258 |
| Amortization of intangibles | 71 | 143 |
| Amortization of subordinated notes issuance costs | 18 | 35 |
| Charges on redemption of subordinated notes | -500 | - |
| Investment securities losses | 159 | -727 |
| Stock-based compensation | 91 | 1,006 |
| Net amortization of investment premiums | 227 | 446 |
| Earnings on bank owned life insurance | 190 | 493 |
| Gain on bank owned life insurance proceeds | 1,191 | 2,399 |
| Gain on sale of asset | 0 | 1,236 |
| Accrued interest receivable | -49 | -3,785 |
| Other assets | -13,020 | 13,940 |
| Other liabilities | 4,149 | -1,627 |
| Net cash from operating activities | 30,201 | -114 |
| Purchases of investment securities available-for-sale | 16,101 | 2,812 |
| Proceeds from sale of investment securities available-for-sale | 0 | 13,688 |
| Proceeds from paydowns of investment securities available-for-sale | -8,877 | -19,580 |
| Proceeds from maturities and calls of investment securities available-for-sale | 2,986 | 9,115 |
| Purchase of restricted investment in bank stocks | 16,957 | 24,216 |
| Proceeds from redemptions of restricted investment in bank stocks | 15,659 | 28,314 |
| Net decrease (increase) in loans | 20,316 | 100,777 |
| Purchases of premises and equipment | 594 | 1,227 |
| Proceeds from sale of premises and equipment | 0 | 2,535 |
| Proceeds from bank owned life insurance | 3,736 | 9,750 |
| Net cash from/(used) by investing activities | -22,710 | -46,050 |
| Net increase in deposits | -2,147 | -123,364 |
| Net change in fhlb advances, short term | 1,500 | -92,500 |
| Redemption of subordinated notes | 20,000 | - |
| Issuance of subordinated notes | 25,000 | - |
| Capital raise, net of issuance costs | -125 | 43,685 |
| Cash dividends paid | 1,739 | 2,955 |
| Purchases of treasury stock | 0 | 158 |
| Net cash from/(used) financing activities | 6,783 | 71,436 |
| Net change in cash and cash equivalents | 14,274 | 25,272 |
| Cash and cash equivalents at beginning of period | 150,334 | - |
| Cash and cash equivalents at end of period | 189,880 | - |
Orange County Bancorp, Inc. DE (OBT)
Orange County Bancorp, Inc. DE (OBT)